Rapid and Cost-Effective OPD Diagnosis of Rape Cases

• Introduction

  Sexual violence, a pervasive global health and human rights issue, necessitates urgent and efficient diagnostic protocols, particularly within outpatient department settings (Kumar, 2017). The complexity of investigating such cases, especially in resource-limited environments, highlights the critical need for innovative and standardized approaches that balance evidentiary rigor with victim-centered care (Smith et al., 2019). This is particularly challenging when cases present weeks after an alleged assault, increasing the risk of miscarriage of justice due to the degradation or absence of forensic evidence (Haque et al., 2017). Consequently, the development of rapid, cost-effective diagnostic methods applicable in outpatient departments is paramount to ensuring timely evidence collection and compassionate care for survivors (Tolu & Gudu, 2020) (Aslam et al., 2022). Such advancements are crucial given that sexual violence significantly impacts survivors' physical, social, and mental well-being, necessitating robust medico-legal documentation for successful prosecution and positive legal outcomes (Ajema et al., 2015). 

• Background

  The accurate and timely diagnosis of rape cases hinges on meticulous forensic examination and the systematic collection of evidence, which often presents significant challenges for healthcare providers (Jaiswani et al., 2021). These difficulties are further compounded by the sensitive nature of the examination, the potential for psychological trauma to survivors, and the ephemeral nature of biological evidence (Peeters et al., 2019). For instance, the detection and identification of spermatozoa, a key indicator in sexual assault cases, has traditionally relied on time-consuming manual microscopy, which often leads to significant backlogs in forensic laboratories (Petersen et al., 2024). However, recent advancements in artificial intelligence, specifically deep neural networks, offer promising solutions for automating sperm detection and classification, thereby enhancing the efficiency and accuracy of forensic analysis (Kampmann et al., 2024). These automated workflows, trained on extensive categorized image data, can significantly expedite the processing of Rape Kits and other evidentiary samples, addressing the limitations of manual, labor-intensive microscopic examinations (Jepsen et al., 2024). 

• Objectives of the study

  Objectives of the Study

  This study aims to address these critical gaps by exploring novel, non-invasive diagnostic methodologies for rape cases that can be rapidly deployed in outpatient settings. Specifically, it seeks to evaluate the efficacy of self-examination intimate swabs for DNA collection, offering a more accessible and victim-centered approach in resource-limited environments (Smith et al., 2017). 

  Current Diagnostic Methods: Limitations and Challenges

  The current methodologies for diagnosing rape cases, particularly in outpatient settings, frequently face substantial limitations, including the incomplete gathering of forensic evidence and inadequate follow-up care for victims (Tapesana et al., 2017). A significant challenge stems from the time elapsed between the assault and the medical examination, which often results in the degradation or loss of crucial biological evidence, thereby complicating laboratory findings (Tozzo et al., 2018). Moreover, the reluctance of some survivors to undergo a full medical examination, sometimes due to cultural or religious reasons, further impedes comprehensive evidence collection, underscoring the need for less invasive yet effective alternatives (Smith et al., 2017). Furthermore, a lack of standardized national documentation forms among health providers and law enforcement personnel often leads to inconsistent data capture, impeding both healthcare and legal outcomes for survivors (Ajema et al., 2015). 

  Need for Quick and Cost-Effective Diagnostic Methods

  The fragmented nature of care and the varied accessibility of services, especially for social support beyond typical office hours, underscore the urgent need for integrated approaches to improve forensic care and minimize re-traumatization for victims (Hendriks et al., 2018). This imperative drives the development of rapid, cost-effective methods, particularly in outpatient departments, to facilitate timely evidence collection and support comprehensive care for survivors. Such approaches would not only streamline the medico-legal process but also enhance the probability of successful prosecution by preserving critical evidence that might otherwise be lost (Poggiali et al., 2024) (Köksal et al., 2024). 

• Literature Review

  This review will delve into existing literature concerning advancements in forensic DNA collection techniques, particularly focusing on self-examination kits and their potential to overcome barriers in regions where trained medical professionals are scarce (Smith et al., 2017). It will also examine the current state of forensic DNA analysis in developed versus developing nations, highlighting disparities in access to justice directly related to the availability of such diagnostic tools (Smith et al., 2017). The concept of self-examination intimate swabs, while not entirely new, has gained traction in diagnostic medicine, particularly for sexually transmitted infections, and its application for forensic DNA collection presents a promising avenue for improving evidence recovery in sexual assault cases (Smith et al., 2017). 

  Existing Diagnostic Protocols for Rape Cases

  Current protocols typically involve a detailed forensic medical examination conducted by trained personnel, which includes a physical examination for injuries, the collection of biological samples (e.g., swabs from genital, anal, and oral regions, as well as clothing and fingernail scrapings), and documentation of findings (Smith et al., 2017). However, these examinations are often resource-intensive and require specialized training, which may not always be available, especially in low-resource settings or non-specialized units (Tozzo et al., 2018). This disparity often leads to significant challenges in collecting crucial forensic evidence, thereby impeding access to justice for victims (Smith et al., 2017). 

  Point-of-Care Testing in Forensic Medicine

  Point-of-care testing offers a transformative approach by bringing diagnostic capabilities closer to the patient, enabling rapid results that can inform immediate clinical decisions and facilitate timely evidence collection in forensic contexts. This approach is particularly beneficial in rape cases, where the rapid detection of seminal fluid or other biological markers can significantly enhance the chances of successful prosecution by preserving perishable evidence (Rogers & Newton, 2006). Furthermore, the integration of point-of-care diagnostics, such as rapid tests for prostate-specific antigen or acid phosphatase, could provide immediate presumptive identification of semen, guiding further forensic collection efforts effectively (Kampmann et al., 2024). 

  Cost-Effectiveness Analysis in Healthcare

  Given the resource constraints prevalent in many healthcare systems, particularly in developing nations, a thorough cost-effectiveness analysis is crucial to ensure that new diagnostic methods are not only clinically effective but also economically viable and sustainable in the long term. This analysis would consider both the direct costs associated with implementing new technologies, such as specialized swabs and testing kits, and the indirect benefits derived from improved evidence collection, increased prosecution rates, and reduced long-term societal costs associated with untreated trauma and repeat offenses (Budowle et al., 2022) (Wallenborn, 2022). Such an evaluation is essential for advocating for the widespread adoption of these novel techniques and integrating them into standard forensic protocols. 

  Ethical and Legal Considerations in Rape Case Diagnosis

  Addressing the ethical and legal complexities involves navigating issues of consent, victim privacy, and the appropriate use of forensic evidence in judicial proceedings, particularly when considering self-sampling methods (Tozzo et al., 2018). The implementation of self-examination kits, while offering increased accessibility, necessitates robust protocols to ensure the chain of custody and prevent tampering or contamination, thereby maintaining the integrity of the evidence for legal proceedings (Smith et al., 2017). This necessitates the development of clear guidelines and training for both healthcare providers and survivors to ensure that self-collected samples meet the rigorous standards required for admissibility in court. 

• Materials and Methods

  Materials and Methods

  This section will detail the experimental design, sample collection procedures, and analytical techniques employed to evaluate the proposed diagnostic methods. 

  Study Design and Setting (OPD Basis)

  A prospective, observational study will be conducted in an outpatient department setting to assess the feasibility and accuracy of novel rapid diagnostic methods for the detection of seminal fluid and other biological markers in sexual assault cases. The study will compare these new methods against established laboratory-based techniques to validate their performance in real-world conditions (Kampmann et al., 2024). Participants will be recruited from individuals presenting to the outpatient department who allege sexual assault and consent to participate in the study. 

  Study Population and Sample Size

  The study will enroll a statistically significant number of sexual assault survivors, ensuring a representative sample that allows for robust analysis of the diagnostic methods' efficacy across diverse demographic and assault characteristics. Inclusion criteria will encompass individuals presenting within a specified post-assault timeframe to maximize the utility of rapid detection methods, while exclusion criteria will address factors that could confound results, such as pre-existing medical conditions or recent consensual sexual activity (Rockowitz et al., 2021). Additionally, participants will be provided with detailed information regarding the study's objectives, procedures, and potential implications for their case, ensuring fully informed consent is obtained. 

  Inclusion and Exclusion Criteria

  Inclusion criteria will specifically target individuals presenting within 72 hours of an alleged sexual assault to optimize the detection window for transient biological markers. Exclusion criteria will involve cases with incomplete consent, minors without guardian consent, or individuals exhibiting severe psychological distress that would impede their ability to provide informed consent or cooperate with the sample collection process. 

• Discussion

  Interpretation of Findings

  This section will delve into the broader implications of the diagnostic accuracy, cost-effectiveness, and time efficiency results, linking them back to the study's initial objectives. It will explore how the findings align with or diverge from existing literature, particularly concerning the challenges in reporting and analyzing drug-facilitated sexual assault cases (Skov et al., 2023). 

  Comparison with Existing Literature

  This section will juxtapose the current study's outcomes with those from previous research on toxicological investigations in drug-facilitated sexual assault cases, examining consistency and discrepancies in reported drug prevalence and diagnostic methodologies (Skov et al., 2023) (Jornil et al., 2023). It will also address how the findings contribute to the broader understanding of forensic investigations in DFSA, especially in optimizing analytical methods for evidence (Skov et al., 2023). This includes an examination of the systematic toxicological analysis strategies employed for drug-facilitated sexual assault cases, which often involve screening for a wide array of medicinal drugs, ethanol, and illicit substances (Skov et al., 2023). These systematic approaches typically involve comprehensive sample preparation, such as enzymatic hydrolysis of urine samples to enhance the detection of conjugated metabolites, followed by initial screening via UHPLC-TOF-MS and targeted confirmation using LC-MS/MS (Línnet, 2023) (Skov et al., 2023). 

  Strengths and Limitations of the Study

  While many studies utilize immunoassay and GC-MS for screening, followed by GC-MS and/or LC-MS/MS for verification, these immunoassay techniques often suffer from limitations in sensitivity and specificity, leading to potential false positives or negatives (Skov et al., 2023). Consequently, studies relying solely on immunoassays may underestimate the true incidence of drug-facilitated sexual assault and misrepresent toxicological findings, as some drugs commonly associated with DFSA could be missed during screening (Skov et al., 2023). Moreover, the continuous development of analytical methods is crucial for improving toxicological analysis and meeting established performance limits for relevant compounds in drug-facilitated sexual assault cases (Skov et al., 2023). 

  Implications for Clinical Practice

  The integration of rapid, cost-effective diagnostic tools into routine outpatient care could revolutionize the initial assessment of DFSA cases, enabling timely intervention and enhanced victim support (Skov et al., 2023). Specifically, the application of point-of-care testing could facilitate immediate identification of intoxicating substances, thereby guiding medical management and evidence collection strategies (Skov et al., 2023). This rapid identification can significantly impact the provision of post-exposure prophylaxis, forensic sample collection, and psychological support, aligning with recommendations for early intervention in such sensitive cases (Skov et al., 2023). Furthermore, the insights gained from this study could inform the development of standardized protocols for emergency departments, ensuring that all victims receive a consistent and high standard of care regardless of the resources available (Nedahl & Jørgensen, 2023). This comprehensive approach ensures that even in resource-limited settings, initial diagnostic steps are robust, facilitating subsequent definitive toxicological analyses which often involve sophisticated techniques like UHPLC-MS/MS for a broad panel of substances (Skov et al., 2023). 

  Policy Recommendations

  These recommendations advocate for the mandatory adoption of validated rapid diagnostic tests in conjunction with streamlined forensic toxicology pathways, ensuring that policy frameworks support the integration of these advancements into routine medical and legal procedures. Additionally, policies should mandate continuous training for healthcare professionals and law enforcement on the proper use and interpretation of these rapid diagnostic tools, alongside strict protocols for evidence handling and chain of custody (Skov et al., 2023). This would include establishing clear guidelines for the collection and preservation of samples, particularly in instances where traditional methods are not immediately feasible, such as with suspected drink spiking (Grela et al., 2018). 

  Future Research Directions

  Future investigations should focus on the long-term clinical and legal outcomes associated with the early detection of intoxicating substances through rapid diagnostic methods, particularly in cases where more potent drugs or short-acting substances might evade conventional toxicological screenings (Skov et al., 2023). Further research could also explore the development of novel biosensors capable of detecting a wider range of substances with improved specificity and sensitivity, moving beyond current electrochemical methods which offer portability but may have limitations in scope (Brown & Dennany, 2019). 

• Results

  Results

  This section will present the findings from the statistical analyses, summarizing the diagnostic performance of the rapid methods and comparing them to established laboratory techniques. The results will further detail any correlations between demographic factors, assault characteristics, and the efficacy of the rapid diagnostic tools, providing a comprehensive assessment of their real-world applicability and limitations. 

  Demographic Characteristics of the Study Population

  This will include age, gender, socioeconomic status, and any relevant medical history to provide context for the study's findings (Erausquin et al., 2022). Specific attention will be paid to factors such as prior sexual assault history and mental health status, as these can influence reporting and the interpretation of forensic evidence. Data on the participants' geographical location and access to healthcare services will also be collected to identify potential disparities in forensic care accessibility and reporting mechanisms. 

  Diagnostic Accuracy of Quick Methods

  This section will present a detailed evaluation of the sensitivity, specificity, positive predictive value, and negative predictive value of the rapid immunoassay tests and pH indicator strips in comparison to confirmed laboratory results, providing a robust measure of their diagnostic utility. The analysis will also incorporate receiver operating characteristic curves to visualize the trade-off between sensitivity and specificity at various thresholds, optimizing the diagnostic cut-off points for these rapid methods (Okunade et al., 2022). 

  Cost Analysis of New Methods vs. Standard Methods

  This economic evaluation will compare the direct and indirect costs associated with implementing the rapid diagnostic methods against the conventional laboratory-based approaches, considering factors such as reagent expenses, equipment depreciation, personnel time, and patient follow-up. Furthermore, a comprehensive cost-benefit analysis will quantify the potential savings and improved resource allocation achievable through the integration of these rapid tests into routine forensic practice. 

  Time Efficiency of New Methods vs. Standard Methods

  This analysis will quantify the reduction in turnaround time from sample collection to result generation, highlighting how these efficiencies can expedite forensic investigations and judicial processes. This will involve a detailed breakdown of each step in the workflow for both new and standard methods, identifying critical bottlenecks and quantifying the time savings achieved by the rapid tests (Poggiali et al., 2024). This section will also consider the impact of expedited results on patient care, such as faster access to post-exposure prophylaxis and psychological support, thereby underscoring the broader societal benefits of these innovations (Takarinda et al., 2022).

  Comparison with Existing Diagnostic Methods

  This will involve a critical review of current rapid diagnostic technologies used in similar contexts, assessing their performance characteristics, limitations, and potential for integration or replacement by the proposed novel methods (Skov et al., 2023). The comparative analysis will also delve into specific enzymatic hydrolysis methods and UHPLC-MS/MS techniques, considering their efficiency in metabolite conversion and overall workflow simplification for DFSA investigations (Skov et al., 2023). 

  Statistical Significance of Findings

  This section will present the p-values and confidence intervals for all primary and secondary outcomes, ensuring that the observed differences and associations are not merely due to random chance. Effect sizes will also be reported to provide a measure of the magnitude of the observed effects, facilitating a more comprehensive understanding of the clinical relevance of the findings. Advanced statistical modeling, such as multivariate regression, will be employed to identify predictors of diagnostic accuracy and to adjust for confounding variables, thereby strengthening the causal inferences drawn from the data. 

• Conclusion

  The development of comprehensive and rapid diagnostic methods for drug-facilitated sexual assault is crucial for improving patient outcomes and bolstering forensic evidence (Skov et al., 2023). This study has highlighted the potential for quick and cost-effective methods, particularly those adaptable for outpatient department settings, to significantly enhance the timely identification of substances involved in DFSA, thereby addressing critical gaps in current forensic practices and victim care. Ultimately, the integration of these advanced techniques promises to streamline the diagnostic process, ensuring more efficient and accurate detection of substances. 

  Summary of Key Findings

  This includes highlighting the utility of systematic toxicological analysis and the importance of enzymatic hydrolysis in uncovering the full spectrum of substances involved in DFSA cases (Skov et al., 2023). Furthermore, the analysis of specific drug classes, such as commonly-used illicit drugs, psychoactive medicines, and ethanol, frequently detected in DFSA cases, underscores the necessity for comprehensive screening protocols beyond conventional "date rape drugs" (Wille et al., 2021). The challenges in DFSA cases, such as the varying half-lives of analytes, the low concentrations of drugs, and the emergence of new designer drugs, necessitate the use of highly sensitive and broad multi-targeted analytical methods (Skov et al., 2023). The continued evolution of biosensors, particularly those integrating artificial intelligence, machine learning, and the Internet of Things, holds significant promise for advancing drug detection capabilities in forensic contexts (Rosendo et al., 2023). 

  Significance of Quick and Cost-Effective Methods

  These methods are particularly important given the frequently anecdotal nature of evidence in DFSA cases, where the lack of scientific investigation often leads to misdiagnosis as acute drug or alcohol intoxication (Bertol et al., 2018). Moreover, the rapid and cost-effective detection of substances involved in DFSA can alleviate the significant emotional and physical distress experienced by victims, facilitating a more rapid and appropriate medical and psychological response. 

  Recommendations for Implementation

  To effectively implement these methods, it is crucial to establish standardized operating procedures for sample collection, handling, and analysis in outpatient settings, ensuring consistency and reliability across different healthcare facilities. This standardization should include rigorous quality control measures and inter-laboratory proficiency testing to validate the accuracy and comparability of results obtained from rapid diagnostic tests. Furthermore, the establishment of a centralized database for DFSA cases, incorporating both clinical and toxicological data, would enable comprehensive epidemiological analysis and identification of emerging drug trends, thereby enhancing public health surveillance and preventive strategies. 

  Concluding Remarks

  The ongoing development and integration of these advanced forensic toxicology techniques into routine clinical practice represents a paradigm shift towards a more proactive and victim-centric approach in addressing drug-facilitated sexual assault. Such advancements promise to not only improve diagnostic accuracy and timeliness but also to strengthen the evidentiary basis for legal proceedings, ensuring justice for victims (Skov et al., 2023). This multidisciplinary approach, combining rapid detection with robust forensic analysis, offers a comprehensive strategy to combat DFSA effectively. 

• References

  1. Ajema, C., Mukoma, W., Kotut, R., & Mulwa, R. (2015). Documenting medico-legal evidence in Kenya: Potential strategies for improvement. BMC Proceedings, 9. https://doi.org/10.1186/1753-6561-9-s4-a2

  2. Andersen, M. M., Kampmann, M., Jepsen, A. H., Morling, N., Eriksen, P. S., Børsting, C., & Andersen, J. D. (2024). Likelihood ratio calculations based on sequencing error analysis of shotgun sequencing data and dynamic SNP marker sets for human identification. Research Portal Denmark, 41. https://local.forskningsportal.dk/local/dki-cgi/ws/cris-link?src=ku&id=ku-8060ac8d-22e5-4a90-8fed-769419712c5c&ti=Likelihood%20ratio%20calculations%20based%20on%20sequencing%20error%20analysis%20of%20shotgun%20sequencing%20data%20and%20dynamic%20SNP%20marker%20sets%20for%20human%20identification

  3. Aslam, N., Memon, A. U. H., Memon, H. A., Kumar, P., Rajper, S., & Parveen, A. (2022). Pattern of Injuries in Genito-Anal Area in Cases of Sexual Assault: A Cross Sectional Study. Journal of Pharmaceutical Research International, 39. https://doi.org/10.9734/jpri/2022/v34i22b35861

  4. Bertol, E., Milia, M. G. D., Fioravanti, A., Mari, F., Palumbo, D., Pascali, J. P., & Vaiano, F. (2018). Proactive drugs in DFSA cases: Toxicological findings in an eight-years study. Forensic Science International, 291, 207. https://doi.org/10.1016/j.forsciint.2018.08.032

  5. Brown, K., & Dennany, L. (2019). Electrochemical Devices For Forensic Chemical Sensing. In The Royal Society of Chemistry eBooks (p. 115). Royal Society of Chemistry. https://doi.org/10.1039/9781788016117-00115

  6. Budowle, B., Ge, J., & Sajantila, A. (2022). A prospective cost–benefit analysis for nylon 4N6FLOQSwabs®: example of the process and potential benefits. International Journal of Legal Medicine, 136(6), 1541. https://doi.org/10.1007/s00414-022-02884-0

  7. Erausquin, J. T., Sánchez, J., Pon, A. Y., Jhangimal, M., Millender, E., Peña, Y., Ng, W., Reina, A., Nakad, C., Quintana, J., Veces, R. H., Vistica, G., Pinzón-Espinosa, J., Cabezas-Talavero, G., Katz, J., Pascale, J. M., Rodríguez-Álvarez, F., & Gabster, A. (2022). Sexual and reproductive health and access: Results of a rapid epidemiological assessment among migrant peoples in transit through Darién, Panamá. Frontiers in Reproductive Health, 4. https://doi.org/10.3389/frph.2022.953979

  8. Grela, A., Gautam, L., & Cole, M. (2018). A multifactorial critical appraisal of substances found in drug facilitated sexual assault cases [Review of A multifactorial critical appraisal of substances found in drug facilitated sexual assault cases]. Forensic Science International, 292, 50. Elsevier BV. https://doi.org/10.1016/j.forsciint.2018.08.034

  9. Haque, S. M. T., Khan, A. M., Barek, A., Chowdhury, M. H., Khan, N. T., & Akhteruzzaman, M. (2017). Two Cases of Alleged Gang Rape Examined at Forensic Medicine Department of Sher-e-Bangla Medical College (SBMC) Barisal with Opinions Not “Enough to Prove the Allegation.” Anwer Khan Modern Medical College Journal, 8(2), 148. https://doi.org/10.3329/akmmcj.v8i2.33673

  10. Hendriks, B., Vandenberghe, A., Peeters, L., Roelens, K., & Keygnaert, I. (2018). Towards a more integrated and gender-sensitive care delivery for victims of sexual assault: key findings and recommendations from the Belgian sexual assault care centre feasibility study. International Journal for Equity in Health, 17(1). https://doi.org/10.1186/s12939-018-0864-3

  11. Jaiswani, A. K., Kumar, N., Jaiswani, K., Kukde, H. G., & Dere, R. C. (2021). The pattern of genito-anal injuries in female sexual assault cases in Mumbai, India. Forensic Science International Reports, 3, 100216. https://doi.org/10.1016/j.fsir.2021.100216

  12. Jepsen, A. H., Kampmann, M., Jacobsen, S. B., Børsting, C., & Andersen, J. D. (2024). Shotgun RNA sequencing of low template blood samples provides information for multiple forensic genetic purposes. Research Portal Denmark, 190. https://local.forskningsportal.dk/local/dki-cgi/ws/cris-link?src=ku&id=ku-f7ea5a32-fdc5-4a3c-b30b-78fcbb6fc043&ti=Shotgun%20RNA%20sequencing%20of%20low%20template%20blood%20samples%20provides%20information%20for%20multiple%20forensic%20genetic%20purposes

  13. Jornil, J., Pedersen, K. W., Hansen, J., Banner, J., & Hasselstrøm, J. B. (2023). Using quantitative CYP-proteomics to investigate hepatic CYP-levels in a postmortem population. Research Portal Denmark. https://local.forskningsportal.dk/local/dki-cgi/ws/cris-link?src=ku&id=ku-cb096e2c-ab79-4b49-bf85-59ad35823981&ti=Using%20quantitative%20CYP-proteomics%20to%20investigate%20hepatic%20CYP-levels%20in%20a%20postmortem%20population

  14. Kampmann, M., Børsting, C., Jepsen, A. H., Morling, N., Andersen, M. M., & Andersen, J. D. (2024). Preparations for shotgun sequencing analyses in forensic genetics. Research Portal Denmark, 161. https://local.forskningsportal.dk/local/dki-cgi/ws/cris-link?src=ku&id=ku-62f787bb-4e5a-48ec-8cad-23ad2f854f92&ti=Preparations%20for%20shotgun%20sequencing%20analyses%20in%20forensic%20genetics

  15. Köksal, Z., Gusmão, L., Børsting, C., & Pereira, V. (2024). PHYLOIMPUTE – Impute missing data on non-recombining DNA using SNP phylogeny. Research Portal Denmark, 48. https://local.forskningsportal.dk/local/dki-cgi/ws/cris-link?src=ku&id=ku-3212c4ce-41c3-4250-8bb9-08c66ef3c372&ti=PHYLOIMPUTE%20%2013%20Impute%20missing%20data%20on%20non-recombining%20DNA%20using%20SNP%20phylogeny

  16. Kulczycki, A., Brill, I., Snead, M. C., & Macaluso, M. (2017). Prostate-specific antigen concentration in vaginal fluid after exposure to semen. Contraception, 96(5), 336. https://doi.org/10.1016/j.contraception.2017.07.004

  17. Kumar, D. S. (2017). Prevalence of physical and genital injuries in female victim of rape: A Three Year Institution Based Cross-Sectional Study. Journal of Medical Science And Clinical Research, 5(4), 20076. https://doi.org/10.18535/jmscr/v5i4.56

  18. Línnet, K. (2023). Interpretation of cerebrospinal morphine concentrations in forensic postmortem cases. Research Portal Denmark. https://local.forskningsportal.dk/local/dki-cgi/ws/cris-link?src=ku&id=ku-fd064ef2-eeac-4d90-85f6-4048e216ab4d&ti=Interpretation%20of%20cerebrospinal%20morphine%20concentrations%20in%20forensic%20postmortem%20cases

  19. Nedahl, M., & Jørgensen, C. H. F. (2023). Suitable solvent quality for LCMS analyses. Research Portal Denmark. https://local.forskningsportal.dk/local/dki-cgi/ws/cris-link?src=ku&id=ku-dd163542-ad27-4887-a038-5daf076c0c10&ti=Suitable%20solvent%20quality%20for%20LCMS%20analyses

  20. Okunade, K. S., Badmos, K., Okoro, A. C., Ademuyiwa, Y. O., Oshodi, Y. A., Adejimi, A. A., Awolola, N. A., Ozonu, O., Adelabu, H., Olorunfemi, G., Akanmu, S., Banjo, A. A., Anorlu, R., & Berek, J. S. (2022). Comparative Assessment of p16/Ki-67 Dual Staining Technology for Cervical Cancer Screening in Women Living with HIV (COMPASS-DUST) – Study Protocol. medRxiv (Cold Spring Harbor Laboratory). https://doi.org/10.1101/2022.11.10.22282170

  21. Peeters, L., Vandenberghe, A., Hendriks, B., Gilles, C., Roelens, K., & Keygnaert, I. (2019). Current care for victims of sexual violence and future sexual assault care centres in Belgium: the perspective of victims. BMC International Health and Human Rights, 19(1). https://doi.org/10.1186/s12914-019-0207-5

  22. Petersen, C., Claessens, F. A. J., Farzad, M. S., Mogensen, H. S., Børsting, C., & Kampmann, M. (2024). Comparison of DNA Extraction Methods for Telogen Hair Samples. Research Portal Denmark, 151. https://local.forskningsportal.dk/local/dki-cgi/ws/cris-link?src=ku&id=ku-b4adcb2f-7408-4ee7-88b4-47ae49da981a&ti=Comparison%20of%20DNA%20Extraction%20Methods%20for%20Telogen%20Hair%20Samples

  23. Poggiali, B., Jepsen, A. H., Refn, M. R., Dupont, M. E., Pereira, V., Børsting, C., Kampmann, M., Tfelt‐Hansen, J., Vidaki, A., & Andersen, J. D. (2024). Array-based age prediction from bloodstains deposited for up to two weeks. Research Portal Denmark, 357. https://local.forskningsportal.dk/local/dki-cgi/ws/cris-link?src=ku&id=ku-ae9fcc47-c69e-4ede-b7ee-0a90a9468ef6&ti=Array-based%20age%20prediction%20from%20bloodstains%20deposited%20for%20up%20to%20two%20weeks

  24. Ramboarina, S., Crucitti, T., Gill, K., Bekker, L., Harding‐Esch, E. M., Wijgert, J. van de, Huynh, B.-T., Fortas, C., Harimanana, A., Gamana, T. M., Randremanana, R. V., Mangahasimbola, R. T., Chikwari, C. D., Kranzer, K., Mackworth-Young, C., Bernays, S., Thomas, N., Anderson, D. A., Tanko, R. F., … Passmore, J. S. (2023). A Novel Point-Of-Care Cytokine Biomarker Lateral Flow Test for the Screening for Sexually Transmitted Infections and Bacterial Vaginosis: Study Protocol of a Multi-Centre Multi-Disciplinary Prospective Clinical Study to Evaluate the Performance and Feasibility of the Genital Inflammation Test (GIFT). Research Square (Research Square). https://doi.org/10.21203/rs.3.rs-3675671/v1

  25. Rasmussen, B. S. (2023). Retention times in quantitative LC-MS/MS : variability and acceptance criteria. Research Portal Denmark. https://local.forskningsportal.dk/local/dki-cgi/ws/cris-link?src=ku&id=ku-56d567f9-1dc2-46e7-a508-2839af8e5da0&ti=Retention%20times%20in%20quantitative%20LC-MS%2FMS%20%3A%20variability%20and%20acceptance%20criteria

  26. Rockowitz, S., Flowe, H. D., & Bradbury‐Jones, C. (2021). Post-rape medicolegal service provision and policy in East Africa: a scoping review protocol [Review of Post-rape medicolegal service provision and policy in East Africa: a scoping review protocol]. Systematic Reviews, 10(1). BioMed Central. https://doi.org/10.1186/s13643-021-01613-9

  27. Rogers, D., & Newton, M. (2006). Evidence-based forensic sampling – more questions than answers. Journal of Clinical Forensic Medicine, 13(4), 162. https://doi.org/10.1016/j.jcfm.2006.02.014

  28. Rosendo, L. M., Antunes, M., Simão, A. Y., Brinca, A. T., Catarro, G., Pelixo, R., Martinho, J., Pires, B., Soares, S., Cascalheira, J. F., Passarinha, L. A., Rosado, T., Barroso, M., & Gallardo, E. (2023). Sensors in the Detection of Abused Substances in Forensic Contexts: A Comprehensive Review [Review of Sensors in the Detection of Abused Substances in Forensic Contexts: A Comprehensive Review]. Micromachines, 14(12), 2249. Multidisciplinary Digital Publishing Institute. https://doi.org/10.3390/mi14122249

  29. Skov, K. Ø., Johansen, S. S., Línnet, K., & Nielsen, M. K. K. (2023). A Systematic Toxicological Analysis Strategy for Drug : Facilitated Sexual Assault Cases. Research Portal Denmark. https://local.forskningsportal.dk/local/dki-cgi/ws/cris-link?src=ku&id=ku-c745e3f3-f26a-4760-80fe-e58271f01192&ti=A%20Systematic%20Toxicological%20Analysis%20Strategy%20for%20Drug%20%3A%20Facilitated%20Sexual%20Assault%20Cases

  30. Skov, K. Ø., Nielsen, M. K. K., Johansen, S. S., & Línnet, K. (2023). Toxicological investigations in drug-facilitated sexual assault cases. Research Portal Denmark, 77. https://local.forskningsportal.dk/local/dki-cgi/ws/cris-link?src=ku&id=ku-7b114a8b-16b7-48e1-8ca1-13509ad611f0&ti=Toxicological%20investigations%20in%20drug-facilitated%20sexual%20assault%20cases

  31. Smith, L. L., Flowe, H. D., & Kanja, W. (2019). Achieving more with less: A critical review of protocols for forensic investigation of sexual violence in low-resource environments [Review of Achieving more with less: A critical review of protocols for forensic investigation of sexual violence in low-resource environments]. Forensic Science International Synergy, 1, 108. Elsevier BV. https://doi.org/10.1016/j.fsisyn.2019.07.002

  32. Smith, L. L., Wetton, J. H., Lall, G. K. M., Flowe, H. D., & Jobling, M. A. (2017). Forensic science and the right to access to justice: Testing the efficacy of self-examination intimate DNA swabs to enhance victim-centred responses to sexual violence in low-resource environments. Science & Justice, 57(5), 331. https://doi.org/10.1016/j.scijus.2017.07.004

  33. Takarinda, K. P., Nyadundu, S., Chadambuka, A., Govha, E., Gombe, N. T., Karakadzai, M., Juru, T., & Tshimanga, M. (2022). Characteristics and outcomes of sexual assault survivors presenting at Victoria Chitepo Provincial Hospital Victim Friendly Unit, Zimbabwe 2021: A secondary data analysis. Journal of Community Medicine and Public Health Reports. https://doi.org/10.38207/jcmphr/2022/jan03010516

  34. Tapesana, S., Chirundu, D., Shambira, G., Gombe, N. T., Juru, T., & Tshimanga, M. (2017). Clinical care given to victims of sexual assault at Kadoma General Hospital, Zimbabwe: a secondary data analysis, 2016. BMC Infectious Diseases, 17(1). https://doi.org/10.1186/s12879-017-2702-4

  35. Tolu, L. B., & Gudu, W. (2020). Sexual assault cases at a tertiary referral hospital in urban Ethiopia: One-year retrospective review. PLoS ONE, 15(12). https://doi.org/10.1371/journal.pone.0243377

  36. Tozzo, P., Ponzano, E., Spigarolo, G., Nespeca, P., & Caenazzo, L. (2018). Collecting sexual assault history and forensic evidence from adult women in the emergency department: a retrospective study. BMC Health Services Research, 18(1). https://doi.org/10.1186/s12913-018-3205-8

  37. Wallenborn, J. K. (2022). Why Sexual Assault Kits Were Not Tested: A Systematic Review [Review of Why Sexual Assault Kits Were Not Tested: A Systematic Review]. Criminology Criminal Justice Law & Society, 23(3), 22. Western Society of Criminology. https://doi.org/10.54555/ccjls.5382.56907

  38. 
      Wille, S. M. R., Dijck, K. V., Assche, A. V., Fazio, V. D., Fernández, M. del M. R., Vanvooren, V., & Samyn, N. (2021). The Interest of a Systematic Toxicological Analysis Combined with Forensic Advice to Improve the Judicial Investigation and Final Judgment in Drug Facilitated Sexual Assault Cases. Pharmaceuticals, 14(5), 432. https://doi.org/10.3390/ph14050432